Palmetto GBA Executive and Leadership Team

Mike Gurrera, the Vice President & Amp. Chief Financial Officer at Palmetto GBA, directs all fiscal planning and budgetary oversight for the organization. Managing the financial health of high-volume claims processing operations, Gurrera ensures that capital allocation aligns with long-term federal contract requirements. The Vice President & Amp. Chief Financial Officer monitors revenue cycles and cost-efficiency metrics to maintain profitability across diverse service lines. By collaborating with executive leadership, Gurrera architects financial strategies that support the expansion of contact center operations. This role involves rigorous risk assessment and the implementation of internal controls to safeguard corporate assets. Mike Gurrera provides the necessary financial transparency required for government auditing standards. Through precise fiscal management, the Vice President & Amp. Chief Financial Officer secures the stability needed for sustained growth in the competitive business services sector, ultimately driving the financial performance of the entire enterprise.

Nancy Lybrand, the Vice President & Chief Financial Officer at Palmetto GBA, manages corporate accounting and financial reporting frameworks. Overseeing the financial integration of technical services, Lybrand ensures that resource distribution supports the high-volume transaction processing demands of federal clients. The Vice President & Chief Financial Officer evaluates investment opportunities and manages liquidity to optimize operational cash flow. By analyzing market trends, Lybrand develops financial models that guide the company through complex regulatory environments. This leadership position requires constant coordination with the board to report on fiscal health and strategic financial objectives. Nancy Lybrand maintains strict adherence to compliance standards, ensuring that all financial activities meet federal mandates. Through the implementation of robust accounting systems, the Vice President & Chief Financial Officer strengthens the fiscal foundation of the organization, enabling the company to scale its service offerings effectively while maintaining profitability across all regional operations.

Margaret Price, the Vice President & Chief Technology Officer at Palmetto GBA, architects the digital infrastructure required for large-scale claims processing. Leading the technology division, Price oversees the development and maintenance of secure platforms that handle sensitive federal data. The Vice President & Chief Technology Officer drives innovation in technical services by integrating advanced automation into existing workflows. By managing the technology roadmap, Price ensures that the company remains at the forefront of digital transformation within the government services industry. This role involves coordinating with cross-functional teams to deploy scalable solutions that enhance contact center efficiency. Margaret Price prioritizes cybersecurity and system reliability to protect the integrity of all processed transactions. Through the strategic application of emerging technologies, the Vice President & Chief Technology Officer optimizes operational performance, ensuring that the company delivers consistent, high-quality technical support to its diverse client base across the nation.

Nella Bishop, the Vice President and Chief Information Officer, Systems and Support at Palmetto GBA, manages the complex information systems that underpin all claims processing activities. Overseeing the systems and support division, Bishop ensures that technical environments remain stable and responsive to high-volume demands. The Vice President and Chief Information Officer, Systems and Support coordinates with IT teams to implement robust data management protocols that support federal contract requirements. By streamlining system architecture, Bishop improves the efficiency of contact center operations and technical service delivery. This leadership role involves managing large-scale software deployments and ensuring seamless integration across all corporate platforms. Nella Bishop maintains a focus on system uptime and data security, which are critical for the company's reputation as a reliable government partner. Through the continuous optimization of information systems, the Vice President and Chief Information Officer, Systems and Support enables the organization to handle increasing transaction volumes with precision.

Miguel Brito, the Chief Medical Officer at Palmetto GBA, provides clinical leadership for the organization's broad healthcare service initiatives. Overseeing medical policy and clinical review processes, Brito ensures that all claims processing activities align with current medical standards and federal guidelines. The Chief Medical Officer collaborates with internal teams to interpret complex clinical data, facilitating accurate and efficient claims adjudication. By establishing clinical protocols, Brito supports the company's mission to provide high-quality service to federal and commercial healthcare programs. This role involves engaging with medical boards and regulatory bodies to maintain compliance with evolving healthcare policies. Miguel Brito drives the clinical strategy that informs the company's approach to medical necessity reviews and coverage determinations. Through the application of rigorous clinical standards, the Chief Medical Officer ensures that the organization maintains its position as a trusted authority in healthcare administration, ultimately improving the accuracy and integrity of the entire claims processing lifecycle.

Jacqueline Lekostaj, the Chief Medical Officer, Molecular Diagnostics at Palmetto GBA, directs clinical strategy specifically for molecular diagnostic testing and related claims. Overseeing the medical review of complex diagnostic procedures, Lekostaj ensures that coverage determinations reflect the latest advancements in genetic and molecular science. The Chief Medical Officer, Molecular Diagnostics collaborates with laboratory partners and clinical experts to establish evidence-based guidelines for diagnostic testing. By analyzing clinical data, Lekostaj supports the development of policies that govern the reimbursement of high-tech medical services. This role involves navigating the intersection of rapidly evolving diagnostic technology and federal healthcare policy. Jacqueline Lekostaj provides the clinical expertise necessary to evaluate the medical necessity of advanced diagnostic interventions. Through the implementation of precise clinical review standards, the Chief Medical Officer, Molecular Diagnostics ensures that the company maintains high accuracy in claims processing, directly impacting the quality and cost-effectiveness of healthcare delivery for federal beneficiaries.

Magdalena Karandikar, the Medical Director & Chief Medical Officer, Moldx & Palmetto Gba at Palmetto GBA, leads the clinical oversight for the MolDX program and broader corporate medical initiatives. Overseeing the assessment of diagnostic technologies, Karandikar ensures that coverage policies are grounded in robust clinical evidence. The Medical Director & Chief Medical Officer, Moldx & Palmetto Gba coordinates with clinical teams to evaluate the medical necessity of molecular tests, ensuring that federal claims processing remains accurate and compliant. By driving the clinical strategy for the MolDX program, Karandikar influences the standards for diagnostic reimbursement across the industry. This role involves extensive collaboration with healthcare providers and laboratory stakeholders to refine clinical guidelines. Magdalena Karandikar provides the medical leadership required to manage complex diagnostic claims effectively. Through the application of rigorous clinical review processes, the Medical Director & Chief Medical Officer, Moldx & Palmetto Gba supports the company's commitment to high-quality, evidence-based healthcare administration.

Angella Charnot- Katsikas, the Medical Director & Chief Medical Officer, Moldx at Palmetto GBA, manages the clinical review and policy development for the MolDX program. Overseeing the evaluation of molecular diagnostic tests, Charnot- Katsikas ensures that all coverage decisions are based on sound clinical data and federal requirements. The Medical Director & Chief Medical Officer, Moldx collaborates with internal clinical staff to maintain the integrity of the diagnostic review process. By establishing clear clinical criteria, Charnot- Katsikas facilitates the efficient processing of claims for advanced medical services. This role involves engaging with the scientific community to stay informed about emerging diagnostic technologies and their clinical utility. Angella Charnot- Katsikas provides the medical expertise necessary to navigate the complexities of molecular diagnostics within the federal healthcare landscape. Through the implementation of evidence-based policies, the Medical Director & Chief Medical Officer, Moldx ensures that the organization delivers accurate and reliable clinical assessments, supporting the overall mission of the company.

Gabriel Bien-Willner, the Medical Director & Chief Medical Officer, Moldx, Palmetto Gba at Palmetto GBA, directs the clinical strategy for the MolDX program and broader medical operations. Overseeing the clinical evaluation of diagnostic tests, Bien-Willner ensures that coverage policies align with the latest medical research and federal standards. The Medical Director & Chief Medical Officer, Moldx, Palmetto Gba coordinates with clinical teams to refine the review process for molecular diagnostics, enhancing the accuracy of claims processing. By engaging with laboratory stakeholders and clinical experts, Bien-Willner fosters a collaborative approach to diagnostic policy development. This role involves providing medical leadership to ensure that the company remains a leader in the administration of complex healthcare services. Gabriel Bien-Willner drives the clinical initiatives that support the company's commitment to high-quality, evidence-based healthcare. Through the application of deep clinical knowledge, the Medical Director & Chief Medical Officer, Moldx, Palmetto Gba ensures that the organization maintains excellence in its medical review and claims processing functions.